{"id":"W2136236728","doi":"10.1016/s0140-6736(09)61248-4","title":"Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women","year":2009,"lang":"en","type":"article","venue":"The Lancet","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":1655,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Manitoba; University of Alberta","funders":"GlaxoSmithKline","keywords":"Medicine; Cohort; Interim analysis; Cervical cancer; Vaccine efficacy; Clinical endpoint; Vaccine trial; Population; HPV infection; Internal medicine; Cervical intraepithelial neoplasia; Vaccination; HPV vaccines; Clinical trial; Oncology; Cancer; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null}